SEC PROPOSES RULES TO MITIGATE CONFLICTS OF INTEREST INVOLVING SECURITY-BASED SWAPS

Washington, D.C., Oct. 13, 2010 – The Securities and Exchange Commission today proposed rules intended to mitigate conflicts of interest for security-based swap clearing agencies, security-based swap execution facilities, and national securities exchanges that post security-based swaps or make them available for trading. Prior to passage of the Dodd-Frank Act, the over-the-counter derivatives market was

SEC PROPOSES RULES TO MITIGATE CONFLICTS OF INTEREST INVOLVING SECURITY-BASED SWAPS Read More »

US Attorney – 44 Members And Associates of Armenian-American Organized Crime Enterprise Charged With $100 Million Medicare Fraud

United States Attorney Defendants Also Charged With Racketeering, Identity Theft, And Money Laundering Crimes Armenian “Vor” Charged With Protecting Alleged Medicare Fraud Scheme PREET BHARARA, the United States Attorney for the Southern District of New York, EDWARD TARVER, the United States Attorney for the Southern District of Georgia, JANICE K. FEDARCYK, the Assistant Director-in-Charge of

US Attorney – 44 Members And Associates of Armenian-American Organized Crime Enterprise Charged With $100 Million Medicare Fraud Read More »

SEC PROPOSES RULES TO REQUIRE ISSUER REVIEW OF ASSETS UNDERLYING ASSET-BACKED SECURITIES

Washington, D.C., Oct. 13, 2010 – The Securities and Exchange Commission today issued a proposal to enhance disclosure to investors in the asset-backed securities market. The SEC’s proposed rules require issuers of asset-backed securities (ABS) to perform a review of the assets underlying the securities and publicly disclose information relating to the review. The proposal

SEC PROPOSES RULES TO REQUIRE ISSUER REVIEW OF ASSETS UNDERLYING ASSET-BACKED SECURITIES Read More »

SEC WARNS OF POTENTIAL INVESTMENT SCAMS TARGETING RECIPIENTS OF BP OIL SPILL PAYOUTS

Washington, D.C., Oct. 13, 2010 – The Securities and Exchange Commission is alerting individuals and small businesses about potential investment frauds targeting those who receive lump sum payouts from BP due to the oil spill in the Gulf. The SEC’s investor alert says that scam artists may target payout recipients with oil spill-related investment opportunities

SEC WARNS OF POTENTIAL INVESTMENT SCAMS TARGETING RECIPIENTS OF BP OIL SPILL PAYOUTS Read More »

PETER B. POPE JOINS JENNER & BLOCK AS A PARTNER IN NEW YORK

LawFuel.com – Law Firm Newswire Service – Former Head of New York State Attorney General Office’s Criminal Division Joins Jenner & Block’s White Collar Defense and Investigations Practice NEW YORK, NY – October 13, 2010 – Jenner & Block today announced that experienced litigator Peter B. Pope has joined the Firm as a partner in

PETER B. POPE JOINS JENNER & BLOCK AS A PARTNER IN NEW YORK Read More »

Watson Pharmaceuticals Inc.: PharmaVitae Profile now available at ReportsandReports

Dallas, TX: ReportsandReports announce Watson Pharmaceuticals Inc.: PharmaVitae Profile Market Research Report in its Store. Browse complete Report at: http://www.reportsandreports.com/reports/7449-watson-pharmaceuticals-inc-pharmavitae-profile.html This analysis examines the historical and forecast performance for Watson in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis with 1-6 year sales forecasts for key drugs. An interactive

Watson Pharmaceuticals Inc.: PharmaVitae Profile now available at ReportsandReports Read More »

Cephalon Inc.: PharmaVitae Profile now available at ReportsandReports

Dallas, TX: ReportsandReports announce Cephalon Inc.: PharmaVitae Profile Market Research Report in its Store. Browse complete Report at: http://www.reportsandreports.com/reports/9245-cephalon-inc-pharmavitae-profile.html This analysis examines the historical and forecast performance for Cephalon in the prescription pharma sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for

Cephalon Inc.: PharmaVitae Profile now available at ReportsandReports Read More »

Scroll to Top